Engflag

Scandishake

Quick links to important sections

Scandishake

Scandishake_DE

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Scandishake

Property Description
Active Ingredient No singular active pharmaceutical ingredient; a matrix of concentrated macronutrients.
Form Oral powder, typically supplied in single-serve sachets.
Pharmacological Class Food for Special Medical Purposes (FSMP) / Oral Nutritional Supplement (ONS).
Common Use Dietary management of malnutrition and weight maintenance/gain.
Origin Derived/Synthetic Combination.

Defining Scandishake: Class, Form, and General Purpose

Scandishake Mix is an Oral Nutritional Supplement (ONS) and is formally classified as a Food for Special Medical Purposes (FSMP), provided as a powder intended for reconstitution. Its primary general purpose is to provide concentrated caloric support to help patients achieve and maintain a necessary body weight, a goal clinically recognized as crucial during periods of illness or recovery.

This classification is essential, as the product is a specially formulated food intended for the dietary management of a disease or condition where distinctive nutritional requirements exist. The brand is commonly available in convenient single-serve sachets and offers a range of flavor options, including unflavored. Unlike general dietary supplements, Scandishake is intended for use under medical supervision and is formulated to address conditions like disease related malnutrition or malabsorption states, confirming its role as a targeted, medically regulated intervention for nutritional deficits.

High-Energy Composition and Nutritional Origin

Scandishake's function is purely nutritional and it contains no singular active pharmaceutical ingredient (API). Instead, it is a combination product that derives its efficacy from a highly concentrated blend of macronutrients. The composition features high levels of carbohydrate (such as Maltodextrin and sucrose) and fat (sourced from vegetable oils), alongside protein (primarily from skimmed milk powder and caseinate).

The preparation is a formulated, derived/synthetic combination product, carefully blended to achieve a high energy density. This specific composition results in a substantial caloric load, which contributes to promoting a positive energy balance. This high-energy characteristic allows patients with poor appetite or limited intake capacity to effectively manage crucial nutritional goals for recovery and maintaining vital body mass.

Regulatory References

  1. NIH/PMC Article on Malnutrition

What side effects are possible with Scandishake?

The official safety information for Scandishake Mix, an Oral Nutritional Supplement (ONS), is defined by its high-caloric, macronutrient composition rather than a pharmacological mechanism. Potential adverse reactions and safety constraints are therefore focused on tolerance and specific patient suitability, as documented in regulatory texts.

Gastrointestinal and Metabolic Tolerance

Adverse effects are commonly categorized under Gastrointestinal Disorders and are often described in regulatory documents as dose-related, meaning they may depend on the amount and rate of consumption. Officially listed potential effects include nausea, vomiting, diarrhea, flatulence, and abdominal discomfort. These effects may be more noticeable upon the initiation of concentrated feeding as the digestive system adjusts.

Safety notes are also documented for the Metabolism and Nutrition Disorders system. The high carbohydrate content carries a risk of hyperglycaemia, particularly in susceptible individuals, necessitating caution and clinical oversight.

Safety Constraints and Contraindications

Certain constraints are imposed due to ingredients and clinical context:

  • Absolute Contraindications: The product is not suitable for individuals with galactosaemia.
  • Allergy and Age Restrictions: It is not suitable for patients with a known cow's milk protein allergy and is officially documented as not suitable for children under 3 years of age.
  • Serious Condition Risk: The potentially serious metabolic complication of Refeeding Syndrome is a critical safety constraint noted in regulatory labeling for this product class when managing severe malnutrition. The product must, therefore, be used under medical supervision and is not suitable as a sole source of nutrition.

Official documents also note caution is required for patients with severe renal or hepatic impairment due to the load from the product's high protein and mineral content.

Overdose and Emergency Response

Overdose and when to seek help

Overdose risk with this high-caloric Oral Nutritional Supplement is classified in regulatory documents as a risk of over-administration, relating to excessive nutritional and osmotic load rather than pharmaceutical toxicity.

Property Official Regulatory Statement (ONS/FSMP Over-administration)
Documented overdose presentations Manifestations include gastrointestinal discomfort (e.g., nausea, vomiting, diarrhea) and serious metabolic disturbances such as hypernatraemia and dehydration leading to hospitalization.
Physiological systems affected Primary systems affected are the fluid/electrolyte balance and metabolic status (glucose regulation).
Population-specific overdose notes Increased hazard for fluid overload or severe metabolic derangement exists in patients with impaired renal function, cardiac insufficiency, or diabetes mellitus.
When immediate medical help is required Immediate medical attention must be sought for persistent or severe systemic symptoms, including signs of profound dehydration or acute cardiac/respiratory distress.

Official Overdose Statements

  • Over-administration is associated with documented risks of hypernatraemia and dehydration.
  • Management is strictly symptomatic and supportive treatment, as no specific antidote is known.
  • Hospital monitoring for serum electrolytes, fluid status, and blood glucose is required in cases of severe over-administration.

Connection to the Overall Overdose Profile

Regulatory guidance defines the overdose profile based on the physiological stress of excessive caloric and solute intake, which can lead to severe and life-threatening fluid and electrolyte imbalance. The official instruction mandates that patients with signs of acute systemic distress seek immediate medical attention to stabilize these documented complications.

Therapeutic Uses of Scandishake

What Scandishake Treats: Main Uses and Benefits

The product is applied across domains where additional symptomatic support for nutritional deficits is needed. It is relevant in situations where symptoms related to insufficient energy intake or nutritional deficits interfere with daily functioning.

The supplement is generally used to help manage symptoms of involuntary weight loss and to address challenges associated with poor nutritional status. It is indicated for the management of disease-related malnutrition and conditions requiring dietary fortification. The primary uses are relevant in conditions characterized by symptoms of disease-related malnutrition, malabsorption states, and situations requiring significant nutritional support.

It is commonly used to help manage symptoms of involuntary weight loss and may assist with functional stability in patients with conditions that cause noticeable physiological strain. The product supports patients during episodes where dietary intake is insufficient to manage the body's high energy needs. The supplement contributes to easing the overall symptom load by providing additional symptomatic support where heightened systemic burden exists. This helps improve day-to-day comfort during symptomatic periods.

Quick Fact: Support for Involuntary Weight Loss and associated Fatigue

Regulatory References

  1. Advisory Committee on Borderline Substances (ACBS) in the UK

Eligibility and Restrictions for Use

Who Can and Cannot Use Scandishake?

Eligibility for Scandishake Mix, which is classified as a Food for Special Medical Purposes, is strictly defined by official regulatory documentation, focusing on contraindications and mandated conditions of use.

Contraindicated Populations and Age Restrictions

Classification Population/Condition
Absolute Contraindication Children under 3 years of age
Comorbidity Restriction Patients with galactosaemia
Route Restriction Intravenous use (product is for enteral use only)

Conditional Eligibility and Usage Rules

Scandishake is generally suitable for adults and children aged three years and older who are experiencing disease-related malnutrition or malabsorption. However, its use is subject to the following official restrictions:

  • The product is not suitable as a sole source of nutrition and is only authorized to be used as a supplement to the normal diet.
  • All use must be managed under medical supervision.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The regulatory profile for Scandishake, classified as a Food for Special Medical Purposes (FSMP), does not include a single Active Pharmaceutical Ingredient (API). Consequently, its official documentation is defined by inherent prohibitions on use rather than conventional pharmaceutical interactions.

The product's regulatory labeling contains no documented pharmacokinetic (e.g., CYP enzyme-mediated) or pharmacodynamic interactions with co-administered pharmaceutical agents, and no specific timing requirements are mandated for administration separation. The entire scope of its interaction-related profile is structured around mandatory restrictions based on its concentrated nutritional composition. These restrictions are classified as absolute contraindications in the official documentation.

Official Interaction Restrictions:

Restriction Context Constraint Statement (Per Regulatory Labeling)
Metabolic Disorder Use is formally prohibited for individuals with galactosaemia. This constraint is due to the presence of lactose components within the product.
Allergy/Immunological Use is formally prohibited for individuals with a known cow's milk protein allergy. This restriction is tied to the product's skimmed milk and caseinate content.
Population-Specific Use is formally prohibited for the age group of children under 3 years of age, as established in the product's regulatory classification.

This structure reflects how authoritative sources define the product's interaction constraints based on the essential compatibility between its composition and a patient’s health condition.

Mechanism of Action

The foundational mechanism of Scandishake involves the sequential and coordinated absorption of its macronutrient components. High-concentration glucose undergoes rapid, passive diffusion through the intestinal wall, entering the systemic circulation to immediately elevate plasma glucose levels. This process is the initial step in augmenting cellular energy substrates. Concurrently, the protein components are hydrolyzed into amino acids, which are then absorbed and serve as essential building blocks for protein synthesis and the replenishment of lean body mass reservoirs. The lipid fraction, rich in fatty acids, is processed via the lymphatic system and integrated into cellular membranes and utilized for ATP production via beta-oxidation. Collectively, this sustained delivery of energy and structural precursors modulates metabolic pathways by mitigating negative energy balance and suppressing catabolic signaling cascades, such as the glucagon-AMPK axis, thereby promoting a net anabolic state at the cellular and systemic level.

Dosage and Administration Information

Scandishake Mix is an Oral Nutritional Supplement (ONS) that is officially designated for enteral use only, meaning it must be consumed through the digestive tract. The product is supplied as a powder in a standard 85-gram sachet, and its administration is strictly required to occur under medical supervision.

Usage Parameter Official Instruction
Route of Administration Oral consumption (Not for intravenous use).
Dosing for Adults 1 to 2 serves per day for patients over 10 years of age.
Preparation Standard 1 sachet (85 g) mixed with 240 milliliters (ml) of fresh, whole milk.
Frequency Pattern Daily use, serving as a supplement to the normal diet.

Age-Group Administration Rules

The official administration guidelines include specific modifications for younger patients. Children aged 5 to 10 years are typically prescribed one full serve per day. For children between 3 and 5 years, the regimen generally involves using half of a sachet per day, prepared with the standard 240 ml of whole milk. The supplement is not suitable for use in children under 3 years of age.

Special Procedural Conditions

When prepared as a drink, proper handling is essential: the mixture must be consumed within 2 hours of preparation, or if refrigerated, stored and consumed within a maximum of 24 hours. The powder can also be used to fortify foods to increase their caloric density, providing flexibility in administration. It is designated for use only as a supplement and not as a sole source of nutrition.

Recent Clinical Evidence

Scandishake: Recent Clinical Evidence

Scandishake Mix is classified as a Food for Special Medical Purposes (FSMP), intended for dietary management under medical supervision. The product is a high-energy nutritional supplement formulated with skimmed milk powder, carbohydrates, and fat, and is used to assist individuals with high energy needs or those struggling with disease-related malnutrition.

Clinical Application and Outcomes

Research has investigated the effectiveness of high-calorie oral nutritional supplements (ONS), like Scandishake, in improving the nutritional status of patients with compromised intake. Studies have focused on conditions requiring significant caloric fortification, such as cystic fibrosis, cancer, and chronic obstructive pulmonary disease (COPD).

Findings suggest that regular supplementation can lead to a demonstrable increase in total daily energy intake and may support weight maintenance or gain in individuals unable to meet their nutritional requirements through diet alone. For instance, studies conducted in specific populations, such as cancer patients, have reported improvements in overall energy levels and body composition over several months of consistent use.

Safety and Tolerability

In clinical evaluations, the supplement is generally reported as well-tolerated. The most frequently noted adverse events are mild and related to the gastrointestinal system, such as bloating or digestive discomfort, particularly in sensitive individuals. Key contraindications noted in product safety information include use in children under 3 years of age, and individuals with galactosaemia or known cow's milk protein allergy.

  • Important Note: Scandishake is not formulated to serve as a sole source of nutrition and is intended only as a supplement to the normal diet.

Frequently Asked Questions (FAQ)

Common questions about Scandishake (FAQ)

Q: Can Scandishake be used by someone who is lactose intolerant?

Regulatory product information indicates that Scandishake Mix contains lactose components. While its use is formally prohibited only for individuals with galactosaemia, the product's lactose content is a key factual element described in the product information.

Q: Does Scandishake contain any caffeine?

The regulatory-listed ingredients for Scandishake Mix, which is classified as a Food for Special Medical Purposes (FSMP), do not include caffeine.

Q: Can a vegetarian or vegan use Scandishake?

Official product information states the product is suitable for a vegetarian diet. However, due to the inclusion of skimmed cow's milk powder and caseinate, it is not classified as suitable for a vegan diet.

Q: Can I continue my regular vitamins while taking Scandishake?

Regulatory product information states that Scandishake Mix is not nutritionally complete in all vitamins and minerals. It is intended only as a supplement to the normal diet because it is not authorized for use as a sole source of nutrition.

Q: What is the texture of Scandishake when it is prepared?

When the powder is prepared according to the official instructions with whole milk, the resulting drink is described in associated product information as having a creamy texture.

Q: Does Scandishake come in different flavors?

Yes, the product is available in several regulatory-approved flavors. These typically include Unflavoured, Vanilla, Chocolate, Strawberry, Banana, and Caramel.

Q: Can people with kidney problems use Scandishake?

Official safety notes indicate that caution is required for individuals with severe renal (kidney) or hepatic (liver) impairment. This precaution is associated with the product’s high protein and mineral content.

Q: Is Scandishake safe for elderly patients?

The official product documents define contraindications based on specific conditions, such as age under three years or galactosaemia. Old age is not listed as a specific contraindication in the official product documents.

Q: What is the calorie count described for a standard serving of Scandishake?

The caloric value of a standard serving, defined as one sachet mixed with 240 mL of whole milk, is officially documented as approximately 588 kilocalories (kcal). The exact value can vary slightly by flavor.

Q: Does Scandishake contain artificial sweeteners or colors?

The officially listed ingredients include flavouring, but the regulatory-sourced lists do not explicitly name artificial sweeteners or artificial colors as components in the product's core composition.

How should Scandishake be stored and disposed of?

How to Store and Dispose of Scandishake

Official regulatory documents define specific conditions for storing Scandishake Mix powder to maintain stability and quality.

Storage Requirements

Item Requirement as Stated in Regulatory Documents
Temperature & Environment Store in a cool, dry place within 5 C to 25 C (41 F to 77 F); Do not refrigerate the dry powder.
Packaging & Safety Keep sealed in the original container and store out of the sight and reach of children.

Stability and Disposal Rules

Once a sachet is opened, the powder must be used within 2–3 days and any unused contents must be discarded thereafter. The prepared drink must be consumed within 2 hours or may be refrigerated for a maximum of 24 hours. Regulatory instructions require patients to always discard unfinished feeds and unused prepared portions that exceed the time limit.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Scandishake found in:

A-Z Index: